Laboratory-Treated Donor Natural Killer Cells and Aldesleukin After Cyclophosphamide , Fludarabine, and Total-Body Irradiation in Treating Patients With Recurrent and/or Metastatic Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
This study has been terminated.
( Withdrawn due to toxicity )
Study NCT00652899
Information provided by National Cancer Institute (NCI)
First Received: April 3, 2008
Last Updated: September 20, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
